Literature DB >> 16941151

Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis.

Motoko Sasaki1, Hiroko Ikeda, Hiroaki Kataoka, Yasuni Nakanuma.   

Abstract

The repair system of damaged biliary mucosa was not fully clarified so far in primary biliary cirrhosis (PBC). Given that related factors of the hepatocyte growth factor (HGF) such as HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1) participate in the repair of injured gastrointestinal mucosa, we investigated the involvement of the HGF/HGFA/HAI-1 system in PBC and control livers. The expression of HGFA, HAI-1, and c-Met was examined in PBC livers (n=24), diseased livers (control, n=30), and normal livers (n=15) by immunohistochemistry and semiquantitative reverse transcriptase-polymerase chain reaction. We examined the expression of HGFA, HAI-1, and c-Met, and the effect of HGF administration on cell proliferation and wound healing, and HAI expression in cultured mouse biliary epithelial cells (BECs). HAI-1 expression was faint in control livers, whereas it was significantly augmented in damaged small bile ducts, bile ductules, and periportal hepatocytes in PBC (p<0.05). HGFA and c-Met were homogeneously expressed in BECs in PBC and control livers. HAI-1 expression was increased at the front of wound healing and the treatment with HGF-enhanced HAI-1 expression, cell proliferation, and wound healing in cultured BECs. HGF/HGFA/HAI-1 system may participate in biliary mucosal repair as reported in gastrointestinal mucosal repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941151     DOI: 10.1007/s00428-006-0257-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).

Authors:  H Kataoka; H Itoh; R Hamasuna; J Y Meng; M Koono
Journal:  Hum Cell       Date:  2001-03       Impact factor: 4.174

Review 3.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

4.  Regulation and function of trefoil factor family 3 expression in the biliary tree.

Authors:  Isao Nozaki; John G Lunz; Susan Specht; Jong-In Park; Andrew S Giraud; Noriko Murase; Anthony J Demetris
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

5.  Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis.

Authors:  Takashi Kamihira; Shinji Shimoda; Kenichi Harada; Akira Kawano; Mizuki Handa; Eishi Baba; Koichi Tsuneyama; Minoru Nakamura; Hiromi Ishibashi; Yasuni Nakanuma; M Eric Gershwin; Mine Harada
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

6.  Serum hepatocyte growth factor levels in liver diseases: clinical implications.

Authors:  G Shiota; J Okano; H Kawasaki; T Kawamoto; T Nakamura
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 7.  Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.

Authors:  Hiroshi Itoh; Hiroaki Kataoka
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

8.  Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.

Authors:  R Halaban; J S Rubin; Y Funasaka; M Cobb; T Boulton; D Faletto; E Rosen; A Chan; K Yoko; W White
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

9.  Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor.

Authors:  A J Strain; L Wallace; R Joplin; Y Daikuhara; T Ishii; D A Kelly; J M Neuberger
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

10.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Koichi Tsuneyama; Kazuyoshi Katayanagi; Yui Yamamoto; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

View more
  5 in total

Review 1.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

Review 2.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

3.  Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Authors:  Wataru Komaki; Tsuyoshi Fukushima; Hiroyuki Tanaka; Hiroshi Itoh; Etsuo Chosa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

4.  Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells.

Authors:  Hiroyuki Tanaka; Tsuyoshi Fukushima; Kenji Yorita; Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2009-02       Impact factor: 4.174

Review 5.  Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.

Authors:  Tsuyoshi Fukushima; Shuichiro Uchiyama; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Int J Mol Sci       Date:  2018-11-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.